EFDID: 29040EFD: View Filing

Issuer: Cahaba Pharmaceuticals, LLC (0001460300) - D

Accession: 0001460300-10-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001460300
  • Entity Name:
    Cahaba Pharmaceuticals, LLC
  • Entity Type:
    Limited Liability Company
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2008)
  • Address:
    103 Carnegie Center, Suite 300
    Princeton, NJ 08540
  • Persons:
    Related Persons 4
    Andrew P. Aromando
    Executive Officer
    William P. Testa
    Executive Officer
    Madding King, III
    Executive OfficerDirector
    J. Rainer Twiford
    Executive OfficerDirector
EDGAR: Offering Information
  • Accession Date:
    12/16/2010
  • First Sale Date:
  • Offering Amount:
    $3,000,000
  • Amount Sold:
    $0
  • Amount Remaining:
    $3,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Michael A. Silverman 4351669 Gottbetter Capital Markets, LLC 20680 AL, CA, PA
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Cahaba Pharmaceuticals, LLCMichel M. MarcouxMichel M. MarcouxAuthorized Company Signatory by Power of Attorney2010-12-16